Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: December 2023

PaxMedica Inc. (NASDAQ: PXMD) Completes Key Type-B FDA Meeting, Discussing Positive Results from PAX-HAT-301 Study

Posted on December 6, 2023 by MissionIR

PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company focused on the development of novel anti-purinergic therapies (“APTs”) for the treatment of Autism Spectrum Disorder (“ASD”) and other serious conditions with intractable neurologic symptoms, recently announced the completion of a type-B meeting … Continue reading →

Posted in PaxMedica Inc. PXMD | Leave a comment

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Advances Solution to Chinese Controls on REE Supply Chain

Posted on December 6, 2023 by MissionIR

China’s recently announced controls on reporting exports of rare earth metallic elements (“REEs”) used strategically for permanent magnets in computerized products is the latest salvo in the ongoing trade war between the large Asian nation and the United States, prompting … Continue reading →

Posted in Ucore Rare Metals Inc. UURAF | Leave a comment

MissionIRNewsBreaks – Correlate Energy Corp. (CIPI) Featured in Equity Research Report

Posted on December 5, 2023 by MissionIR

Correlate (OTCQB: CIPI), a company at the forefront of the clean distributed energy revolution, was featured in a comprehensive research report by Harbinger Research, LLC. Dated Oct. 31, 2023, the piece sheds light on Correlate, underscoring its potential in an … Continue reading →

Posted in Correlate Infrastructure Partners Inc. CIPI | Leave a comment

MissionIRNewsBreaks – Safety Shot (NASDAQ: SHOT) Releases Updated Report on Litigation

Posted on December 5, 2023 by MissionIR

Safety Shot (NASDAQ: SHOT), makers of the first patented beverage on Earth that helps people feel better faster by reducing blood alcohol content and boosting clarity, is reporting on its newly filed lawsuit against Capybara Research. According to the update, the … Continue reading →

Posted in Safety Shot Inc. SHOT | Leave a comment

MissionIRNewsBreaks — SenesTech Inc. (NASDAQ: SNES) CEO Featured in Latest Stock2Me Podcast

Posted on December 5, 2023 by MissionIR

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, is in the spotlight during a recent episode of The Stock2Me Podcast. Hosted by IBN, a multifaceted communications organization engaged in connecting public companies to the investment … Continue reading →

Posted in SenesTech Inc. SNES | Leave a comment

MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Announces Mullen THREE Delivery to Retail Partner for Sale to Customers

Posted on December 5, 2023 by MissionIR

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has delivered its All-Electric Class 3 EV, the Mullen THREE, to the Randy Marion Automotive Group (“RMA”) in North Carolina. Mullen’s retail dealership partner, RMA is one of the largest … Continue reading →

Posted in Mullen Automotive Inc. MULN | Leave a comment

MissionIRNewsBreaks — Cepton Inc. (NASDAQ: CPTN) COO Talks Integration of LiDAR in Latest Proactive Interview

Posted on December 5, 2023 by MissionIR

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, is spotlighted in a recent Proactive interview. During the interview, Cepton chief commercial officer Mitch Hourtienne and Proactive host Steve Darling talked about LiDAR technology, with Hourtienne specifically … Continue reading →

Posted in Cepton Inc. CPTN | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Positive Interim Results in Ongoing GLP-1 Human Pilot Study

Posted on December 5, 2023 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced additional positive interim results from its ongoing human pilot study that seeks to provide an early-stage indication of whether DehydraTECH(TM) processing could improve oral drug delivery characteristics … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

PaxMedica Inc. (NASDAQ: PXMD) Closes Public Offering of Approximately $7 Million and Continues Pursuing ASD Pipeline

Posted on December 5, 2023 by MissionIR

PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company focused on the development of novel anti-purinergic therapies (“APTs”) for the treatment of Autism Spectrum Disorder (“ASD”) and other serious conditions with intractable neurologic symptoms, recently reported the closing of its public offering. … Continue reading →

Posted in PaxMedica Inc. PXMD | Leave a comment

MissionIRNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Featured in Recent H.C. Wainwright & Co. Research Report with ‘Buy’ Rating, $3 PT

Posted on December 4, 2023 by MissionIR

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, is spotlighted in a recent H.C. Wainwright & Co. research report. The report “is initiating coverage on PaxMedica, an emerging firm developing novel formulations of suramin for … Continue reading →

Posted in PaxMedica Inc. PXMD | Leave a comment